In the last trading session, 96303.0 shares of the Adial Pharmaceuticals Inc (NASDAQ:ADIL) were traded, and its beta was 1.20. Most recently the company’s share price was $0.69, and it changed around -$0.03 or -4.06% from the last close, which brings the market valuation of the company to $5.45M. ADIL currently trades at a discount to its 52-week high of $3.00, offering almost -334.78% off that amount. The share price’s 52-week low was $0.57, which indicates that the current value has risen by an impressive 17.39% since then.
Adial Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ADIL as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information
Instantly ADIL has showed a red trend with a performance of -4.06% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.7400 on recent trading dayincreased the stock’s daily price by 6.76%. The company’s shares are currently down -31.70% year-to-date, but still up 4.86% over the last five days. On the other hand, Adial Pharmaceuticals Inc (NASDAQ:ADIL) is -3.52% down in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 34.05%. Adial Pharmaceuticals Inc earnings are expected to increase by 61.03% in 2025, but the outlook is positive 41.31% per year for the next five years.
ADIL Dividends
Adial Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 40.6 shares worth $28008.0, making up 0.51% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 9.36 shares worth around $6455.0, which represents about 0.12% of the total shares outstanding.
